Hostname: page-component-5c6d5d7d68-wp2c8 Total loading time: 0 Render date: 2024-08-22T05:46:42.289Z Has data issue: false hasContentIssue false

A Case-Control Study of Nosocomial Ampicillin-Resistant Enterococcal Infection and Colonization at a University Hospital

Published online by Cambridge University Press:  21 June 2016

Daniel J. Sexton*
Affiliation:
Depatiments of Medicine, Duke University, Medical Center, Durham, North Carolina Infection Control Unit, Duke University, Medical Center, Durham, North Carolina
Lizzie J. Harrell
Affiliation:
Microbiology, Duke University, Medical Center, Durham, North Carolina Clinical Microbiology Laboratory, Duke University, Medical Center, Durham, North Carolina
Jackie J. Thorpe
Affiliation:
Clinical Microbiology Laboratory, Duke University, Medical Center, Durham, North Carolina
Debra L. Hunt
Affiliation:
Infection Control Unit, Duke University, Medical Center, Durham, North Carolina
L. Barth Reller
Affiliation:
Depatiments of Medicine, Duke University, Medical Center, Durham, North Carolina Pathology, Duke University, Medical Center, Durham, North Carolina Clinical Microbiology Laboratory, Duke University, Medical Center, Durham, North Carolina
*
Box 3605, Duke University Medical Center, Durham NC 27710

Abstract

Objective:

To assess risk factors for colonization and nosocomial infection with ampicillin-resistant enterococci (ARE).

Design:

Patients with ampicillin-resistant enterococci were compared retrospectively by logistic regression analysis with controls harboring susceptible strains. ARE were characterized by whole plasmid DNA analysis and restriction enzyme analysis of plasmid (REAP) DNA with EcoRI.

Setting:

The study was done at a 1,125 bed, tertiary-care teaching hospital in North Carolina with patients from whom enterococci were isolated from June 1, 1989, to March 30, 1991.

Patients:

The final study group comprised 44 cases with nosocomially-acquired colonization or infection with ARE and 100 controls with ampicillin-susceptible strains. Clinical and epidemiological risk factors for ARE were abstracted by chart review.

Results:

After controlling for age and site of infection, patients with ARE were more likely to have been admitted previously to our hospital and to have received third-generation cepha-losporins and clindamycin. However, only advanced age and clindamycin therapy were independently associatedwith presence of ARE. REAP with EcoRI showed 20 groups of enterococci on 19 different wards.

Conclusions:

These results suggest that ARE are endemic and multifocal in origin in our hospital and that advanced age and use of clindamycin are important selective risk factors for ARE colonization and infection (Infect Control Hosp Epidemiol1993;14:629-635).

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1993 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Murray, BE. The life and times of the Enterococcus . Clin Microbiol Rev 1990;3:4665.CrossRefGoogle ScholarPubMed
2. Murray, BE. p-lactamase producing enterococci. Antimicrob Agents Chemother 1992;36:23552359.CrossRefGoogle Scholar
3. Murray, BE, Mederski-Samoraj, B. Transferable p-lactamase: a new mechanism for in vitro penicillin resistance in Streptococcus faecalis . J Clin Invest 1983;72:11681171.CrossRefGoogle Scholar
4. Rice, LB, Eliopoulos, GM, Wennersten, C, Goldmann, D, Jacoby, GA, Moellering, RC Jr. Chromosomally mediated p-lactamase production and gentamicin resistance in Enterococcus faecalis . Antimicrob Agents Chemother 1991;35:272276.CrossRefGoogle Scholar
5. Coudron, PE, Mayhall, CG, Facklam, RR, Spadora, AC, Lamb, VA, Lybrand, MR, Dalton HP Streptococcus faecium outbreak in a neonatal intensive care unit. Clin Microbiol 1984;20:10441048.CrossRefGoogle Scholar
6. Patterson, JE. Wanger, A, Zscheck, KK, Zervos, MJ, Murray, BE. Molecular epidemiology of (β-lactamase-producing enterococci. Antimicrob Agents Chemother 1990;34:302305.CrossRefGoogle ScholarPubMed
7. Oster, SE, Chirurgi, VA, Goldberg, AA, Aiken, S, McCabe, RE. Ampicillin-resistant enterococcal species in an acute care hospital. Antimicrob Agents Chemother 1990;34:18211823.CrossRefGoogle Scholar
8. Gray, JW, Stewart, D, Pedler, SJ. Species identification and antibiotic susceptibility testing of enterococci isolated from hospitalized patients. Antimicrob Agents Chemother 1991;35:19431945.CrossRefGoogle ScholarPubMed
9. Markowitz, SM, Wells, VD, Williams, DS, Stuart, CG, Coudron, PE, Wone, ES. Antimicrobial susceptibility and molecular epidemiology of β-lactamase-producing, aminoglycoside-resistant isolates of Enterococcus faecalis. Antimicrob Agents Chemother 1991;35:10751080.CrossRefGoogle ScholarPubMed
10. Coudron, PE, Markowitz, SM, Wong, ES.Isolation of a p-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium . Antimicrob Agents Chemother 1992;36:11251126.10.1128/AAC.36.5.1125CrossRefGoogle Scholar
11. Boyce, JM, Opal, SM, Potter-Bynoe, G, et al. Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother 1992;36:10321039.CrossRefGoogle ScholarPubMed
12. Boyle, JF, Soumakis, SA, Rendo, A. et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:12801285.CrossRefGoogle ScholarPubMed
13. Livomese, LL Jr, Dias, S, Samel, C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112116.CrossRefGoogle Scholar
14. Murray, BE, Lopavdo, HA, Rubeglio, EA, Frosolono, M, Singh, KV. Intrahospital spread of a single gentamicin-resistant, p-lactamase-producing strain of Enterococcus faecalis in Argentina. Antimicrob Agents Chemother 1992;36:230232.CrossRefGoogle Scholar
15. Zervos, MJ, Kauffman, CA, Therasse, PM, Bergman, AG, Mikesell, TS, Schaberg, DR. Nosocomial infection by gentamicin-resistant Streptococcus faecalis . Ann Intern Med 1987;106:687691.CrossRefGoogle ScholarPubMed
16. Rhinehart, E, Smith, NE, Wennerstein, C, et al. Rapid dissemination of β-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med 1990;323:18141818.CrossRefGoogle Scholar
17. Patterson, JE. Masecar, BL, Kauffman, CA, Shaberg, DR, Hierholzer, WI. Zervos, MJ. Gentamicin resistance plasmids of enterococci from diverse geographic areas are heterogenous. Infect Dis 1988;158:212216.CrossRefGoogle Scholar
18. Sapico, FL, Canawati, HN, Ginunas, VJ, et al. Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? Clin Microbiol 1989;27:20912095.CrossRefGoogle ScholarPubMed
19. Zervos, MJ, T&openning, MS, Schaberg, DR, Therasse, PM, Medendorp, SV, Kauffman, CA. High-level aminoglycoside-resistant enterococci. Colonization of nursing home and acute care patients. Arch Intern Med 1987;147:15911594.CrossRefGoogle Scholar
20. Huycke MM, , Spiegel, CA, Gilmore, MS. Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 1991;35:16261634.CrossRefGoogle ScholarPubMed
21. Axelrod, R Talbot, GM. Risk factors for acquisition of gentamicin-resistant enterococci. Arch Intern Med 1989;149:13971401.CrossRefGoogle ScholarPubMed
22. Wells, VD, Wong, ES, Murray, BE, Coudron, PE, Williams, DS, Markowitz, SM. Infections due to the beta-lactamase producing, high-level gentamicin-resistant Enterocccus faecalis . Ann Intern Med 1992;116:285292.CrossRefGoogle Scholar
23. Garner, JS, Jarvis, WR, Emori, TG, Hosan, TC, Hughes, JM. CDC defintions for nosocomial infections. 1988. Am J Infect Control 1988;16:128140. [Erratum, Am J Infect Control 1988;16:177].CrossRefGoogle Scholar
24. Facklam, RR, Washington, JA. Streptococcus and related catalase-negative gram-positive cocci. In: Balows, A, Hausler, WJ Jr, Herrmann, KL, Isenberg, LTD, Shadomy, HJ, eds. Manual of Clinical Microbiology. 5th ed. Washington, DC: American Society for Microbiology, 1991:238257.Google Scholar
25. National Committee for Clinical Laboratory Standards. Approved Standard, M2-A4: Performance Standards for Antimicrobial Disk Susceptibility Tests. 4th ed. Villanova PA NCCLS; 1990.Google Scholar
26. DeGuglielmo, MA, George, CG, Kloos, WE. Selection of colony, plasmid, and virulence variants of Staphylococcus epidermidis NRC 853 during growth in continuous cultures exposed to erythromycin. Appl Environ Microbiol 1991;57:10181025.CrossRefGoogle Scholar
27. Hosmer, DW, Lemeshow, S. Applied Logistic Regression. New York, NY: Wiley & Sons, 1989.Google Scholar
28. Hall, LMC, Duke, B, Urwin, G, Guiney, M. Epidemiology of Enterococcus faecalis urinary tract infection in a teaching hospital in London, United Kingdom. J Clin Microbiol 1992;30:19531957.CrossRefGoogle Scholar
29. Donabedian, SM, Chow, JW, Boyce, JM, et al. Molecular typing of ampicillin-resistant, non-p-lactamase-producing Enterococcus faecium isolates from diverse geographic areas. J Clin Microbiol 1992;30:27572761.CrossRefGoogle ScholarPubMed
30. Nachamkin, I, Axelrod, R Talbot, GH, et al. Multiple high-level-aminoglycoside-resistant enterococci isolated from patients in a university hospital. Clin Microbiol 1988;26:12871291.CrossRefGoogle Scholar
31. Wenzel, RP, Osterman, CA, Hunting, KJ, Gwaltney, JM Jr. Hospital-acquired infections: I. Surveillance in a university hospital. Am J Epidemiol 1976;103:251260.CrossRefGoogle ScholarPubMed
32. Jones, RN, Thornsberry, C. Gram-positive superinfections: a consequence of modern β-lactam chemotherapy. Antimicrob Newsletter 1985;2:1723.CrossRefGoogle Scholar
33. Murray, BE, Singh, KY Heath, JD, Sharma, BR, Weinstock, GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. Clin Microbiol 1990;28:20592063.CrossRefGoogle ScholarPubMed